Showing results (351-360 of 431) with videos related to
Sort By:
Pageof 44
Archives of Pathology & Laboratory Medicine|March 6, 2018
Circulating Tumor DNA Analysis in Patients With Cancer: American Society of Clinical Oncology and College of American Pathologists Joint ReviewJason D Merker, Geoffrey R Oxnard, Carolyn Compton, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 30, 2021
A Randomized Trial of Fulvestrant, Everolimus, and Anastrozole for the Front-line Treatment of Patients with Advanced Hormone Receptor-positive Breast Cancer, SWOG S1222Halle C F Moore, William E Barlow, George Somlo, et al.Cancer Research|February 18, 2017
Targeted Degradation of BET Proteins in Triple-Negative Breast CancerLongchuan Bai, Bing Zhou, Chao-Yie Yang, et al.Breast Cancer Research and Treatment|May 13, 2018
A phase II study evaluating the efficacy of zoledronic acid in prevention of aromatase inhibitor-associated musculoskeletal symptoms: the ZAP trialCesar A Santa-Maria, Aditya Bardia, Amanda L Blackford, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 21, 2010
Gene polymorphisms in cyclophosphamide metabolism pathway,treatment-related toxicity, and disease-free survival in SWOG 8897 clinical trial for breast cancerSong Yao, William E Barlow, Kathy S Albain, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 3, 2009
Report from the Radiation Therapy Committee of the Southwest Oncology Group (SWOG): Research Objectives Workshop 2008Paul Okunieff, Lisa A Kachnic, Louis S Constine, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 13, 2009
Nitric oxide synthase variants and disease-free survival among treated and untreated breast cancer patients in a Southwest Oncology Group clinical trialJi-Yeob Choi, William E Barlow, Kathy S Albain, et al.NPJ Breast Cancer|October 30, 2025
Understanding the association between body mass index and chemotherapy dose reductions in women treated for stage I-IIIA breast cancerJenna Bhimani, Kelli O'Connell, Grace B Gallagher, et al.International Journal of Cancer|July 6, 2024
Patient characteristics associated with delayed time to adjuvant chemotherapy among women treated for stage I-IIIA breast cancerJenna Bhimani, Kelli O'Connell, Sonia Persaud, et al.Journal of the National Cancer Institute|November 3, 2025
Associations between age and chemotherapy dose reductions in women with stage I-IIIA breast cancerErin J Aiello Bowles, Kelli O'Connell, Jenna Bhimani, et al.Pageof 44